In case you missed it: October 26 to October 30

It was a very busy week for the Contemporary Pediatrics team.

This week’s top articles included:

FDA approves Sklice for OTC use

Sklice (ivermectin) lotion, 0.5% has been approved for over-the-counter (OTC) use by the US Food and Drug Administration (FDA) in children aged 6 months and older.

The toll of COVID-19 and quarantine on college students’ mental health

The impact of COVID-19 on mental health is hard to measure. A report offers a look at how quarantine impacted the mental health of university students.

Impact of preoperative blood transfusion on postoperative outcomes in newborns

Many newborns get a blood transfusion because of surgery, but could preoperative blood transfusion do more harm than good?

Toll of environmental exposures on teen psychosocial stress

A new report looks into how environmental exposures can negatively impact an adolescent’s perceived stress.

Related Videos
Benjamin Maxwell, MD, chief of child and adolescent psychiatry, Rady Children’s Hospital, San Diego, California | Image provided
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx -
Pfizer's infant RSV vaccine receives FDA Advisory Committee's support | Image Credit: Dr_Microbe - Image Credit: Dr_Microbe
Thomas R. Young, MD | Image Credit: Author provided
J. Thomas Megerian, MD, PhD, FAAP | Author provided
© 2023 MJH Life Sciences

All rights reserved.